We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
About this guideline
Adopted by the TGA: 13 March 2025
Overseas effective date: 19 September 2017
Replaces: Guideline on the assessment of clinical safety and efficacy in the preparation of European Union herbal monographs for well-established and traditional herbal medicinal products (Draft revision 1) (EMA/HMPC/104613/2005 Rev 1) (Adopted by the TGA 28 February 2020)
Categories: Multidisciplinary | Herbal medicinal products
TGA annotations:
Applicants must be able to demonstrate an established tradition of use for traditional use indications in Australia. Please refer to the Understanding listed and registered complementary medicine regulation, which identify traditional use as generally equating to three generations of human use.
- Where EU guidelines adopted in Australia include references to EU legislation (including EC Directives and Regulations), the requirements contained in the referenced EU legislation are not applicable to the evaluation of medicines by the TGA.
- All documents and other content published by the European Medicines Agency (EMA) on this website are under the copyright and other intellectual property rights ownership of the EMA. Please refer to Legal notice | European Medicines Agency for further information.
For more information see International scientific guidelines adopted in Australia.